AMAG Pharmaceuticals Appoints Chief Compliance Officer

AMAG Pharmaceuticals announced the appointment of Tracy Palmer Berns as chief compliance officer effective immediately. She will report to Joseph Vittiglio, general counsel and senior vice president of legal affairs and quality.

In her role at AMAG, Ms. Berns will be responsible for the company’s compliance program and therapeutic-product legal team and provide legal advice on regulatory, development, pharmacovigilance and quality matters. Additionally, she will further strengthen the organization’s culture to continue to prioritize ethics and compliance.

Ms. Berns brings more than 20 years of healthcare industry experience, creating effective compliance programs focused on policies, training, risk assessment, monitoring, investigations and discipline. Most recently, she served as the vice president of ethics and compliance within the Minimally Invasive Therapies Group at Medtronic, reporting to the president of the division and Medtronic’s chief ethics and compliance officer.

Prior to this position, she was vice president and chief compliance and regulatory counsel at Covidien, where she was responsible for the company’s global compliance program to ensure compliance with relevant laws and regulations.  

"I am confident that Tracy’s broad experience leading compliance programs in other healthcare organizations will be beneficial to AMAG today, and in the future as we continue to expand our product portfolio," said Mr. Vittiglio. "Her insights and expertise will be helpful as we continue to develop and market novel therapeutics to address significant unmet medical needs."

Ms. Berns received her law degree from Columbia University and her Bachelor’s degree at Knox College in Illinois.